CorMedix (NASDAQ: CRMD) reported Q3 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $6.81 million .

For earnings history and earnings-related data on CorMedix (CRMD) click here.